President Donald Trump signed an executive order allowing research for certain psychedelic drugs used to treat mental health disorders, specifically for veterans. The order also directs the Food and Drug administration (FDA) to expedite its review of new treatments. The move applies to certain drugs, including psychedelics, that are currently in the "advanced stages of clinical trials. The announcement was made by podcaster Joe Rogan, who had been critical of the president over the U.S. operation in Iran. The administration also highlighted the potential inclusion of Ibogaine, a psychedelic drug used in other countries to treat PTSD, under the Right to Try Act.